Free Trial
NASDAQ:VIVS

Organovo (VIVS) Stock Price, News & Analysis

$1.75 -0.03 (-1.41%)
As of 10:44 AM Eastern

About Organovo Stock (NASDAQ:VIVS)

Key Stats

Today's Range
$1.75
$1.77
50-Day Range
N/A
52-Week Range
$1.56
$21.96
Volume
5,930 shs
Average Volume
522,321 shs
Market Capitalization
$3.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. It is also developing in vivo liver tissues to treat end-stage liver, life-threatening, and orphan diseases. The company was incorporated in 2007 and is headquartered in Solana Beach, California.

Receive VIVS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organovo and its competitors with MarketBeat's FREE daily newsletter.

VIVS Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

VIVS Stock Analysis - Frequently Asked Questions

Organovo's stock was trading at $1.91 at the beginning of 2025. Since then, VIVS shares have decreased by 7.1% and is now trading at $1.7750.
View the best growth stocks for 2025 here
.

Shares of VIVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biological Products, Except Diagnostic Substances
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VIVS
Web
N/A
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$122,000.00
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$3.36 million
Optionable
N/A
Beta
1.20
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:VIVS) was last updated on 6/4/2025 by MarketBeat.com Staff
From Our Partners